Cancer Research UK logo.
SearchDonate
  • Search

A trial looking at afatinib for people with a type of bone cancer called chordoma

Overview

Cancer types:

Bone cancer, Sarcoma, Secondary cancers

Status:

Closed

Phase:

Phase 2

Details

This trial is for people with chordoma that has come back or spread to another part of the body (advanced chordoma).

Everyone taking part has receptors for a protein called epidermal growth factor (EGFR positive) on the surface of their cancer cells.

Recruitment start: 27 March 2019

Recruitment end: 2 October 2022

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr Sandra Strauss

Supported by

Boehringer Ingelheim

Leiden University Medical Center

University College London Hospital NHS Foundation Trust

Last reviewed: 03 Oct 2022

CRUK internal database number: 15512

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.